HOUSE OF REPRESENTATIVES
THE THIRTY-SECOND LEGISLATURE
INTERIM OF 2023
|
COMMITTEE ON HEALTH & HOMELESSNESS |
|
Rep. Della Au Belatti, Chair |
|
Rep. Jenna Takenouchi, Vice Chair |
|
Rep. Terez Amato |
Rep. John M. Mizuno |
|
Rep. Greggor Ilagan |
Rep. Scott Y. Nishimoto |
|
Rep. Bertrand Kobayashi |
Rep. Diamond Garcia |
NOTICE OF INFORMATIONAL BRIEFING
|
DATE: |
Wednesday, November 15, 2023 |
|
TIME: |
9:00 AM |
|
PLACE: |
Via Videoconference & Conference Room 329, State Capitol 415 South Beretania Street |
PHOTO ID REQUIRED FOR ENTRANCE TO THE STATE CAPITOL
BUILDING HOURS: 7:00 AM TO 5:00 PM, MONDAY TO FRIDAY
A live stream link of this meeting will be available online shortly before the scheduled start time.
Click here for the live stream of this meeting via YouTube.
A G E N D A
In 2021, states across the nation began entering into historic multistate settlement agreements to resolve lawsuits holding pharmaceutical companies accountable for their roles in the promotion of opioids and the addiction crisis that ensued and continues to afflict individuals and communities across the nation. Due to these settlement agreements, it has been reported, in part, that the State of Hawai‘i received $1,999,960.95 in an agreement reached with McKinsey & Company, and is expected to receive an estimated $13 million in an agreement reached with Purdue Pharma and the Sackler Family, and an estimated $73 million in agreements reached with Johnson & Johnson, AmerisourceBergen, Cardinal Health, and McKesson.
The purpose of this briefing is to update the Committee and the public on Hawai‘i’s opioid initiatives based upon the receipt of these settlement funds, with a focus on the status, procedures, progress, and expenditure plans of the Opioid Settlement Advisory Committee created in 2022. In addition, the Committee and the public will be updated on best practices that have developed across the nation for the allocation, expenditures, and utilization of these and other government funds in tackling the problems associated with drug addiction and the need for treatment solutions in our communities.
The following persons and their respective organizations have been invited to participate in this briefing:
1. Kenneth A. Fink, MD, MGA, MPH, Director, Hawai‘i State Department of Health (DOH), or his designee;
John Valera, AICP, Administrator, Alcohol & Drug Abuse Division (ADAD), DOH;
Katia Worley, State Opioid Director/Hawai‘i Opioid Initiative Coordinator, DOH;
2. Timothy Hansen, Member, Hawai‘i Opioid Settlement Advisory Committee,
Executive Assistant, Office of the Mayor, Hawai‘i County;
3. Bryan C. Yee, Deputy Attorney General, Department of the Attorney General, State of Hawai‘i; and
4. Shelley R.Weizman, JD, Project Director, Addiction & Public Policy Initiative, O’Neill Institute for National & Global Health Law; Adjunct Professor of Law, Georgetown University Law Center.
No public testimony will be accepted.
If you require special assistance or auxiliary aids and/or services to participate in the informational briefing (i.e., sign language interpreter or wheelchair accessibility), please contact the Committee Clerk at (808) 586-9425 or email your request for an interpreter to HouseInterpreter@Capitol.hawaii.gov at least 24 hours prior to the hearing for arrangements. Prompt requests help to ensure the availability of qualified individuals and appropriate accommodations.
For further information, please call the Committee Clerk at (808) 586-9425.
|
|
|
________________________________________ Rep. Della Au Belatti Chair |
|
|
|
________________________________________ Rep. Scott K. Saiki Speaker of the House |